CYLD Promotes TNF-α-Induced Cell Necrosis Mediated by RIP-1 in Human Lung Cancer Cells

Cylindromatosis-A Protective Molecule against Liver Diseases

(2016) Claus Hellerbrand et al.   MEDICINAL RESEARCH REVIEWS

Nivolumab: A Review in Advanced Squamous Non-Small Cell Lung Cancer

(2015) Gillian M. Keating   DRUGS

Albumin-Bound Paclitaxel: A Review in Non-Small Cell Lung Cancer

(2015) Hannah A. Blair et al.   DRUGS

Lung cancer screening: a systematic review of clinical practice guidelines

(2015) Z. Y. Li et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Prognostic value of Bcl-2 expression in patients with non-small-cell lung cancer: a meta-analysis and systemic review

(2015) Jie Zhang et al.   OncoTargets and Therapy

MKP1 mediates chemosensitizer effects of E1a in response to cisplatin in non-small cell lung carcinoma cells

(2015) Francisco J. Cimas et al.   Oncotarget

Review of aerobic glycolysis and its key enzymes - new targets for lung cancer therapy

(2015) Xue-bing Li et al.   Thoracic Cancer

Hypoxia suppresses cylindromatosis (CYLD) expression to promote inflammation in glioblastoma: possible link to acquired resistance to anti-VEGF therapy

(2015) Jianying Guo et al.   Oncotarget

The cylindromatosis gene product, CYLD, interacts with MIB2 to regulate notch signalling

(2015) Neil Rajan et al.   Oncotarget

Truncation of the Catalytic Domain of the Cylindromatosis Tumor Suppressor Impairs Lung Maturation

(2015) Eirini Trompouki et al.   NEOPLASIA

Clinical significance of CYLD downregulation in breast cancer

(2014) Mitsuhiro Hayashi et al.   BREAST CANCER RESEARCH AND TREATMENT

The LEF1/CYLD axis and cIAPs regulate RIP1 deubiquitination and trigger apoptosis in selenite-treated colorectal cancer cells

(2014) P Wu et al.   Cell Death & Disease

Smac mimetic primes apoptosis-resistant acute myeloid leukaemia cells for cytarabine-induced cell death by triggering necroptosis

(2013) Joerg Chromik et al.   CANCER LETTERS

CYLD controls c-MYC expression through the JNK-dependent signaling pathway in hepatocellular carcinoma

(2013) Rajeswara Rao Pannem et al.   CARCINOGENESIS

Biological agents alone or in combination as second-line therapy in advanced non-small-cell lung cancer: systematic review of randomized studies

(2012) Fausto Petrelli et al.   Expert Review of Anticancer Therapy

Molecular Profiling to Optimize Treatment in Non-Small Cell Lung Cancer: A Review of Potential Molecular Targets for Radiation Therapy by the Translational Research Program of the Radiation Therapy Oncology Group

(2012) Natalie L. Ausborn et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

CYLD Inhibits Tumorigenesis and Metastasis by Blocking JNK/AP1 Signaling at Multiple Levels

(2011) P. M. de Marval et al.   Cancer Prevention Research

Contemporary Results of Surgical Resection of Non-small Cell Lung Cancer After Induction Therapy: A Review of 549 Consecutive Cases

(2011) Stephen A. Barnett et al.   Journal of Thoracic Oncology

Dysregulation of TNFα-induced necroptotic signaling in chronic lymphocytic leukemia: suppression of CYLD gene by LEF1

(2011) P Liu et al.   LEUKEMIA

Potential Role of CYLD (Cylindromatosis) as a Deubiquitinating Enzyme in Vascular Cells

(2008) Yoichi Takami et al.   AMERICAN JOURNAL OF PATHOLOGY

Tumor Suppressor Cylindromatosis Acts as a Negative Regulator forStreptococcus pneumoniae-induced NFAT Signaling

(2008) Tomoaki Koga et al.   JOURNAL OF BIOLOGICAL CHEMISTRY